Dr. Manojkumar Bupathi, MD, MS
Claim this profileRocky Mountain Cancer Centers - Colorado Springs, N. Nevada
Studies Cancer
Studies Ovarian Cancer
9 reported clinical trials
21 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
2Ovarian Cancer
Stage IV
Stage III
BRCA1
Affiliated Hospitals
Clinical Trials Manojkumar Bupathi, MD, MS is currently running
HC-7366 + Belzutifan
for Kidney Cancer
This is a Phase 1b, open-label, multicenter, safety, tolerability and efficacy study of HC-7366 in combination with belzutifan (WELIREG™). This is a multipart study that consists of a HC-7366 monotherapy cohort, a combination dose escalation, and a combination dose expansion. Approximately 80 patients will be enrolled in this study (up to 20 patients will be enrolled into the HC-7366 monotherapy cohort, up to 30 patients into the combination dose escalation, and up to 30 patients into the combination dose expansion). The primary purpose of this study is to determine the maximum tolerated dose of HC-7366 in combination with belzutifan in patients with locally advanced (inoperable) or metastatic RCC with predominantly clear cell histology, irrespective of VHL gene mutation status.
Recruiting1 award Phase 1
ICP-192
for Solid Tumors
This is a multi-center, open-label, phase I/II clinical study to evaluate ICP-192 in patients with advanced solid tumors and FGFR gene alterations. It consists of two parts: Part I (Phase I), dose escalation and Part II (Phase II), dose expansion.
Recruiting1 award Phase 1 & 29 criteria
More about Manojkumar Bupathi, MD, MS
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Manojkumar Bupathi, MD, MS has experience with
- Carboplatin
- Trastuzumab
- Abemaciclib
- Oregovomab
- Paclitaxel
- Ladiratuzumab Vedotin
Breakdown of trials Manojkumar Bupathi, MD, MS has run
Cancer
Ovarian Cancer
Fallopian Tube Cancer
Ovarian Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Manojkumar Bupathi, MD, MS specialize in?
Manojkumar Bupathi, MD, MS focuses on Cancer and Ovarian Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Manojkumar Bupathi, MD, MS currently recruiting for clinical trials?
Yes, Manojkumar Bupathi, MD, MS is currently recruiting for 2 clinical trials in Littleton Colorado. If you're interested in participating, you should apply.
Are there any treatments that Manojkumar Bupathi, MD, MS has studied deeply?
Yes, Manojkumar Bupathi, MD, MS has studied treatments such as Carboplatin, Trastuzumab, Abemaciclib.
What is the best way to schedule an appointment with Manojkumar Bupathi, MD, MS?
Apply for one of the trials that Manojkumar Bupathi, MD, MS is conducting.
What is the office address of Manojkumar Bupathi, MD, MS?
The office of Manojkumar Bupathi, MD, MS is located at: Rocky Mountain Cancer Centers - Colorado Springs, N. Nevada, Littleton, Colorado 80120 United States. This is the address for their practice at the Rocky Mountain Cancer Centers - Colorado Springs, N. Nevada.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.